JP2010518868A - 前立腺癌の生存及び再発 - Google Patents

前立腺癌の生存及び再発 Download PDF

Info

Publication number
JP2010518868A
JP2010518868A JP2009551054A JP2009551054A JP2010518868A JP 2010518868 A JP2010518868 A JP 2010518868A JP 2009551054 A JP2009551054 A JP 2009551054A JP 2009551054 A JP2009551054 A JP 2009551054A JP 2010518868 A JP2010518868 A JP 2010518868A
Authority
JP
Japan
Prior art keywords
prostate cancer
gene
expression
recurrence
metastasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009551054A
Other languages
English (en)
Japanese (ja)
Inventor
マ，シャオ−ジュン
ウー，チン−リー
ジー． アーランダー，マーク
Original Assignee
バイオセラノスティクス，インコーポレイティド
ザ ジェネラル ホスピタル コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオセラノスティクス，インコーポレイティド, ザ ジェネラル ホスピタル コーポレイション filed Critical バイオセラノスティクス，インコーポレイティド
Publication of JP2010518868A publication Critical patent/JP2010518868A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2009551054A 2007-02-23 2008-02-25 前立腺癌の生存及び再発 Pending JP2010518868A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89147707P 2007-02-23 2007-02-23
PCT/US2008/054820 WO2008103971A2 (fr) 2007-02-23 2008-02-25 Survie au cancer de la prostate et récurrence de ce dernier

Publications (1)

Publication Number Publication Date
JP2010518868A true JP2010518868A (ja) 2010-06-03

Family

ID=39710787

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009551054A Pending JP2010518868A (ja) 2007-02-23 2008-02-25 前立腺癌の生存及び再発

Country Status (6)

Country Link
EP (2) EP2754720A1 (fr)
JP (1) JP2010518868A (fr)
CN (1) CN101720358A (fr)
CA (2) CA2684897A1 (fr)
ES (1) ES2527062T3 (fr)
WO (1) WO2008103971A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0701662D0 (en) 2006-12-14 2007-03-07 Blatchford & Sons Ltd A lower limb prosthesis
US8628585B2 (en) 2007-12-14 2014-01-14 Blatchford Products Limited Lower limb prosthesis
US8722875B2 (en) 2008-09-23 2014-05-13 Silence Therapeutics Gmbh Means for inhibiting the expression of Orc-1
US20120041274A1 (en) 2010-01-07 2012-02-16 Myriad Genetics, Incorporated Cancer biomarkers
KR20110111462A (ko) * 2009-01-07 2011-10-11 미리어드 제네틱스, 인크. 암 바이오마커
EP3812469A1 (fr) 2010-07-07 2021-04-28 Myriad Genetics, Inc. Signatures géniques pour le pronostic du cancer
WO2012030840A2 (fr) 2010-08-30 2012-03-08 Myriad Genetics, Inc. Signatures génétiques pour le diagnostic et le pronostic du cancer
CN102968558B (zh) * 2012-11-14 2015-11-18 叶定伟 一种预测初诊前列腺癌骨转移风险的装置
WO2014078700A1 (fr) 2012-11-16 2014-05-22 Myriad Genetics, Inc. Signatures génétiques utilisées en vue du pronostic d'un cancer
EP3143160B1 (fr) 2014-05-13 2019-11-06 Myriad Genetics, Inc. Signatures génétiques utilisées en vue du pronostic d'un cancer
GB201616912D0 (en) 2016-10-05 2016-11-16 University Of East Anglia Classification of cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003053223A2 (fr) * 2001-12-21 2003-07-03 Whitehead Institute For Biomedical Research Diagnostic du cancer de la prostate et prevision des resultats d'un traitement par analyse de l'expression genetique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6285701B1 (en) 1998-08-06 2001-09-04 Lambda Physik Ag Laser resonator for improving narrow band emission of an excimer laser
JP4813746B2 (ja) * 2000-07-10 2011-11-09 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 染色体３ｐ２１．３遺伝子は腫瘍サプレッサーである
US7229774B2 (en) * 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
US7204987B2 (en) * 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US7890267B2 (en) * 2006-03-31 2011-02-15 Ordway Research Institute Prognostic and diagnostic method for cancer therapy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003053223A2 (fr) * 2001-12-21 2003-07-03 Whitehead Institute For Biomedical Research Diagnostic du cancer de la prostate et prevision des resultats d'un traitement par analyse de l'expression genetique

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6013012153; Ｉｎｔｅｒｎａｔｉｏｎａｌ　ｊｏｕｒｎａｌ　ｏｆ　ｃａｎｃｅｒ．　２００１，　Ｖｏｌ．９６，　Ｎｏ．３，　ｐ．１９８-２０９ *
JPN6013012156; Ｃａｎｃｅｒ．　２００５，　Ｖｏｌ．１０４，　Ｎｏ．２，　ｐ．２９０-２９８ *

Also Published As

Publication number Publication date
ES2527062T3 (es) 2015-01-20
CA2939539A1 (fr) 2008-08-28
CN101720358A (zh) 2010-06-02
EP2121988A4 (fr) 2010-06-09
WO2008103971A9 (fr) 2013-06-06
EP2121988B1 (fr) 2014-12-17
WO2008103971A3 (fr) 2009-12-10
CA2684897A1 (fr) 2008-08-28
EP2754720A1 (fr) 2014-07-16
WO2008103971A2 (fr) 2008-08-28
EP2121988A2 (fr) 2009-11-25

Similar Documents

Publication Publication Date Title
JP7042784B2 (ja) 遺伝子発現を用いた前立腺癌の予後を定量化する方法
EP2121988B1 (fr) Survie au cancer de la prostate et récurrence de ce dernier
JP6140202B2 (ja) 乳癌の予後を予測するための遺伝子発現プロフィール
JP5940517B2 (ja) 内分泌治療下における乳癌再発を予測するための方法
US20110177971A1 (en) Method for diagnosing the stage of a thyroid tumor
EP1888785A2 (fr) Analyse moléculaire de la thyroide par aspiration à l'aiguille
JP2008521412A (ja) 肺癌予後判定手段
US20180148794A1 (en) Methods of prostate cancer prognosis
EP2875157A1 (fr) Méthodes, kits et compositions pour réaliser une évaluation clinique d'un cancer prostatique
WO2008151110A2 (fr) Diagnostic moléculaire et typage de variants du cancer des poumons
EP2304631A1 (fr) Algorithmes de prediction de resultat pour des patientes atteintes de cancer du sein traite par chimiotherapie avec atteinte ganglionnaire
JP2007516692A (ja) 乳癌の徴候
JP2015057055A (ja) 腫瘍グレード分類と癌の予後診断
JP2011525106A (ja) 瀰漫性ｂ大細胞型リンパ腫のマーカーおよびその使用方法
KR101815184B1 (ko) 비-소세포 폐암의 예후를 측정하기 위한 진단 방법
WO2016118670A1 (fr) Dosage d'expression multigénique pour la stratification des patients dans le cas de métastases hépatiques colorectales après résection
US20180051342A1 (en) Prostate cancer survival and recurrence
JP2012531925A (ja) チボザニブ応答予測
CN101457254B (zh) 用于肝癌预后的基因芯片和试剂盒
WO2013002750A2 (fr) Détermination de l'origine d'une tumeur

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110225

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130319

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130618

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130625

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130919

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20131015